A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System

International Journal of Pharmaceutics

Volumn 321, Issue 1-2, 2006, Pages 1-11

  Dokoumetzidis, Aristides ^a   Macheras, Panos ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Bioavailability; Drug dissolution; Drug release

Indexed keywords

PHENYTOIN; QUINIDINE GLUCONATE;

AQUEOUS SOLUTION; BIOEQUIVALENCE; CHRONOLOGY; CONTROLLED DRUG RELEASE; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG CLASSIFICATION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG PENETRATION; DRUG RESEARCH; DRUG SCREENING; DRUG SOLUBILITY; GASTROINTESTINAL ABSORPTION; HYDRODYNAMICS; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; MATHEMATICAL MODEL; PHARMACEUTICAL ENGINEERING; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROGNOSIS; REVIEW; SUSTAINED DRUG RELEASE; TECHNOLOGY; THEORETICAL STUDY; UNITED STATES;

ANIMALS; BIOLOGICAL AVAILABILITY; BIOPHARMACEUTICS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; HUMANS; INTESTINAL ABSORPTION; RESEARCH; SOLUBILITY;

EID: 33747373878     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.07.011     Document Type: Review

References (102)

1. Amidon G.L., Lennernas H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification-the correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharm. Res. 12 (1995) 413-420
2. Avnir D. The Fractal Approach to Heterogeneous Chemistry (1989), John Willey & Son, Chichester
3. Bates T.R., Gibaldi M., and Kanig J.L. Rate of dissolution of griseofulvin and hexoestrol in bile salt solutions. Nature 210 (1966) 1331-1333
4. Blythe R.H., Grass G.M., and Macdonnell D.R. The formulation and evaluation of enteric coated aspirin tablets. Am. J. Pharm. Sci. Support. Public Health 131 (1959) 206-216
5. Bochner F., Hooper W.D., Tyrer J.H., and Eadie M.J. Factors involved in an outbreak of phenytoin intoxication. J. Neurol. Sci. 16 (1972) 481-487
6. Boxenbaum H. Absorption potential and its variants. Pharm. Res. 16 (1893)
7. Bruner L., and Tolloczko S. Über die Auflösungsgeschwindigkeit Fester Körper. Z. Phys. Chem. 35 (1900) 283-290
8. Brunner E. Reaktionsgeschwindigkeit in heterogenen Systemen. Z. Phys. Chem. 43 (1904) 56-102
9. Bunde A., Havlin S., Nossal R., Stanley H.E., and Weiss G.H. On controlled diffusion-limited drug release from a leaky matrix. J. Chem. Phys. 83 (1985) 5909-5913
10. Campagna F.A., Cureton G., Mirigian R.A., and Nelson E. Inactive prednisone tablets USP XVI. J. Pharm. Sci. 52 (1963) 605-606
11. Chapron D.J., Kramer P.A., Mariano S.L., and Hohnadel D.C. Effect of calcium and antacids on phenytoin bioavailability. Arch. Neurol. 36 (1979) 436-438
12. Chiou W.L. Mechanism of increased rates of dissolution and oral absorption of chloramphenicol from chloramphenicol-urea solid dispersion system. J. Pharm. Sci. 60 (1971) 1406-1408
13. Cloyd J.C., Gumnit R.J., and Lesar T.S. Reduced seizure control due to spoiled phenytoin capsules. Ann. Neurol. 7 (1980) 191-193
14. D'Arcy D.M., Corrigan O.I., and Healy A.M. Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability. J. Pharm. Pharmacol. 57 (2005) 1243-1250
15. D'Arcy D.M., Corrigan O.I., and Healy A.M. Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics-dissolution rate implications. Eur. J. Pharm. Sci. 27 (2006) 259-267
16. Danckwerts P.V. Significance of liquid-film coefficients in gas absorption. Ind. Eng. Chem. 43 (1951) 1460-1467
17. Dokoumetzidis A., Papadopoulou V., and Macheras P. Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function. Pharm. Res. 23 (2006) 256-261
18. Dressman J.B., Amidon G.L., and Fleisher D. Absorption potential: estimating the fraction absorbed for orally administered compounds. J. Pharm. Sci. 74 (1985) 588-589
19. Dressman J.B., Amidon G.L., Reppas C., and Shah V.P. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 15 (1998) 11-22
20. Edwards L.J. The dissolution and diffusion of aspirin in aqueous media. Trans. Faraday Soc. 47 (1951) 1191-1210
21. Elworthy P.H., Florence A.T., and Macfarlane C.B. Solubilization by Surface-Active Agents and its Applications in Chemistry and the Biological Sciences (1968), Chapman & Hall, London
22. Enscore D.J., Hopfenberg H.B., and Stannett V.T. Effect of particle-size on mechanism controlling normal-hexane sorption in glassy polystyrene microspheres. Polymer 18 (1977) 793-800
23. Faassen F., and Vromans H. Biowaivers for oral immediate-release products: implications of linear pharmacokinetics. Clin. Pharmacokinet. 43 (2004) 1117-1126
24. FDA, 2000. Guidance for Industry, Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms based on a Biopharmaceutics Classification System. FDA/CDER.
25. FDA, 2002. Guidance for Industry on Food-Effect Bioavailability and Fed Bioequivalance Studies; availability. FDA.
26. Filleborn V.M. Am. J. Pharm. 120 (1948) 233
27. Finholt J.L. Influence of formulation on dissolution rate. In: Leeson L.J., and Carstensen J.T. (Eds). Dissolution Technology (1974), American Pharmaceutical Association, Washington, DC 106-146
28. FIP. FIP guidelines for dissolution testing of solid oral products. Pharm. Ind. 42 (1981) 334-343
29. Fraser E.J., Leach R.H., and Poston J.W. Bioavailability of digoxin. Lancet 2 (1972) 541
30. Fu J.C., Hagemeir C., Moyer D.L., and Ng E.W. Unified mathematical-model for diffusion from drug-polymer composite tablets. J. Biomed. Mater. Res. 10 (1976) 743-758
31. Galia E., Nicolaides E., Horter D., Lobenberg R., Reppas C., and Dressman J.B. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm. Res. 15 (1998) 698-705
32. Gibaldi M., and Feldman S. Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. J. Pharm. Sci. 56 (1967) 1238-1242
33. Hendeles L., Weinberger M., Milavetz G., Hill M., and Vaughan L. Food-induced dose-dumping from a once-a-day theophylline product as a cause of theophylline toxicity. Chest 87 (1985) 758-765
34. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 50 (1961) 874-875
35. Hixson A.W., and Crowell J.H. Dependence of reaction velocity upon surface and agitation. Ind. Eng. Chem. 23 (1931) 923-931
36. Jounela A.J., Pentikainen P.J., and Sothmann A. Effect of particle size on the bioavailability of digoxin. Eur. J. Clin. Pharmacol. 8 (1975) 365-370
37. Kasim N.A., Whitehouse M., Ramachandran C., Bermejo M., Lennernas H., Hussain A.S., Junginger H.E., Stavchansky S.A., Midha K.K., Shah V.P., and Amidon G.L. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol. Pharm. 1 (2004) 85-96
38. Kaus L.C., Gillespie W.R., Hussain A.S., and Amidon G.L. The effect of in vivo dissolution, gastric emptying rate, and intestinal transit time on the peak concentration and area-under-the-curve of drugs with different gastrointestinal permeabilities. Pharm. Res. 16 (1999) 272-280
39. Kosmidis K., Argyrakis P., and Macheras P. Fractal kinetics in drug release from finite fractal matrices. J. Chem. Phys. 119 (2003) 6373-6377
40. Kosmidis K., Argyrakis P., and Macheras P. A reappraisal of drug release laws using Monte Carlo simulations: the prevalence of the Weibull function. Pharm. Res. 20 (2003) 988-995
41. Kostewicz E.S., Carlsson A.S., Hanisch G., Nilsson R.G., Lofgren L., and Abrahamsson B. Comparison of dog and human intestinal fluid and its impact on solubility estimations. Eur. J. Pharm. Sci. 17 (2002) S111
42. Lagas M., and Jonkman J.H.G. Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained-release tablet. Eur. J. Clin. Pharmacol. 24 (1983) 761-767
43. Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J. Pharm. Pharmacol. 24 (1972) 979-981
44. Lansky P., and Weiss M. Does the dose-solubility ratio affect the mean dissolution time of drugs?. Pharm. Res. 16 (1999) 1470-1476
45. Levich V.G. Physicochemical Hydrodynamics (1962), Prentice-Hall, Englewood Cliffs, NY
46. Levy G. Effect of particle size on dissolution and gastrointestinal absorption rates of pharmaceuticals. Am. J. Pharm. Sci. Support. Public Health 135 (1963) 78-92
47. Levy G. Effect of dosage form properties on therapeutic efficacy of tolbutamide tablets. Can. Med. Assoc. J. 90 (1964) 978-979
48. Levy G., Hall N.A., and Nelson E. Studies on inactive prednisone tablets USP XVI. Am. J. Hosp. Pharm. 21 (1964) 402
49. Lindenbaum J., Mellow M.H., Blackstone M.O., and Butler Jr. V.P. Variation in biologic availability of digoxin from four preparations. N. Engl. J. Med. 285 (1971) 1344-1347
50. Lindenberg M., Kopp S., and Dressman J.B. Classification of orally administered drugs on the World Health Organization Model list of essential medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm. 58 (2004) 265-278
51. Lipowski S., 1934. The UK Patent Office 523, 594.
52. Macheras P., and Argyrakis P. Gastrointestinal drug absorption: Is it time to consider heterogeneity as well as homogeneity?. Pharm. Res. 14 (1997) 842-847
53. Macheras P., and Iliadis A. Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and Heterogeneous Approaches (2006), Springer, New York
54. Macheras P., Koupparis M., and Antimisiaris S. An invitro model for exploring CR theophylline milk-fat interactions. Int. J. Pharm. 54 (1989) 123-130
55. Macheras P., Koupparis M., and Apostolelli E. Dissolution of four controlled-release theophylline formulations in milk. Int. J. Pharm. 36 (1987) 73-79
56. Macheras P.E., and Symillides M.Y. Toward a quantitative approach for the prediction of the fraction of dose absorbed using the absorption potential concept. Biopharm. Drug Dispos. 10 (1989) 43-53
57. MacLeod C., Rabin H., Ruedy J., Caron M., Zarowny D., and Davies R. Comparative bioavailability of three brands of ampicillin. Can. Med. Assoc. J. 107 (1972) 203-209
58. Martin C.M., Rubin M., O'Malley W.G., Garagusi V.F., and McCauley C.E. Brand, generic drugs differ in man. JAMA 205 (medical news section) (1968) 23
59. Maturu P.K., Prasad V.K., Worsley W.N., Shiu G.K., and Skelly J.P. Influence of a high-fat breakfast on the bioavailability of theophylline controlled-release formulations-an in vitro demonstration of an in vivo observation. J. Pharm. Sci. 75 (1986) 1205-1206
60. McCarthy L.G., Bradley G., Sexton J.C., Corrigan O.I., and Healy A.M. Computational fluid dynamics modeling of the paddle dissolution apparatus: agitation rate, mixing patterns, and fluid velocities. AAPS PharmSciTech 5 (2004) E31
61. McCarthy L.G., Kosiol C., Healy A.M., Bradley G., Sexton J.C., and Corrigan O.I. Simulating the hydrodynamic conditions in the United States Pharmacopeia paddle dissolution apparatus. AAPS PharmSciTech 4 (2003) E22
62. Miyamoto S. A theory of the rate of solution of solid into liquid. Trans. Faraday Soc. 29 (1933) 789-794
63. Morrison A.B., and Campbell J.A. Tablet disintegration and physiological availability of drugs. J. Pharm. Sci. 54 (1965) 1-8
64. Nelson E. Solution rate of theophylline salts and effects from oral administration. J. Am. Pharm. Assoc. 46 (1957) 607-614
65. Nernst W. Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen. Z. Phys. Chem. 47 (1904) 52-55
66. Noyes A.A., and Whitney W.R. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc. 19 (1897) 930-934
67. Oh D.M., Curl R.L., and Amidon G.L. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm. Res. 10 (1993) 264-270
68. Papadopoulou V., Kosmidis K., Vlachou M., and Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int. J. Pharm. 309 (2006) 44-50
69. Pedersen B.L., Brondsted H., Lennernas H., Christensen F.N., Mullertz A., and Kristensen H.G. Dissolution of hydrocortisone in human and simulated intestinal fluids. Pharm. Res. 17 (2000) 183-189
70. Pedersen S. Delay in the absorption rate of theophylline from a sustained-release theophylline preparation caused by food. Br. J. Clin. Pharmacol. 12 (1981) 904-905
71. Pedersen S., and Moller-Petersen J. Erratic absorption of a slow-release theophylline sprinkle product. Pediatrics 74 (1984) 534-538
72. Peppas N.A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60 (1985) 110-111
73. Persson E.M., Gustafsson A.S., Carlsson A.S., Nilsson R.G., Knutson L., Forsell P., Hanisch G., Lennernas H., and Abrahamsson B. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm. Res. 22 (2005) 2141-2151
74. Polli J.E., Yu L.X., Cook J.A., Amidon G.L., Borchardt R.T., Burnside B.A., Burton P.S., Chen M.L., Conner D.P., Faustino P.J., Hawi A.A., Hussain A.S., Joshi H.N., Kwei G., Lee V.H., Lesko L.J., Lipper R.A., Loper A.E., Nerurkar S.G., Polli J.W., Sanvordeker D.R., Taneja R., Uppoor R.S., Vattikonda C.S., Wilding I., and Zhang G. Summary workshop report: biopharmaceutics classification system-implementation challenges and extension opportunities. J. Pharm. Sci. 93 (2004) 1375-1381
75. Prasad V.K., Shah V.P., Knight P., Malinowski H., Cabana B.E., and Meyer M.C. Importance of media selection in establishment of in vitro in vivo relationships for quinidine gluconate. Int. J. Pharm. 13 (1982) 1-7
76. Rinaki E., Dokoumetzidis A., and Macheras P. The mean dissolution time depends on the dose/solubility ratio. Pharm. Res. 20 (2003) 406-408
77. Rinaki E., Dokoumetzidis A., Valsami G., and Macheras P. Identification of biowaivers among class II drugs: theoretical justification and practical examples. Pharm. Res. 21 (2004) 1567-1572
78. Rinaki E., Valsami G., and Macheras P. The power law can describe the 'entire' drug release curve from HPMC-based matrix tablets: a hypothesis. Int. J. Pharm. 255 (2003) 199-207
79. Rinaki E., Valsami G., and Macheras P. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio. Pharm. Res. 20 (2003) 1917-1925
80. Ritger P.L., and Peppas N.A. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Rel. 5 (1987) 37-42
81. Sanghvi T., Ni N., and Yalkowsky S.H. A simple modified absorption potential. Pharm. Res. 18 (2001) 1794-1796
82. Shah V.P., Prasad V.K., Freeman C., Skelly J.P., and Cabana B.E. Phenytoin II: in vitro-in vivo bioequivalence standard for 100-mg phenytoin sodium capsules. J. Pharm. Sci. 72 (1983) 309-310
83. Siepmann J., Faisant N., Akiki J., Richard J., and Benoit J.P. Effect of the size of biodegradable microparticles on drug release: experiment and theory. J. Control. Rel. 96 (2004) 123-134
84. Siepmann J., Faisant N., and Benoit J.P. A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations. Pharm. Res. 19 (2002) 1885-1893
85. Siepmann J., and Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 48 (2001) 139-157
86. Skelly J.P. Bioavailability of sustained release dosage forms-relationship with in-vitro dissolution. In: Yacobi A., and Holperin-Walega E. (Eds). Oral Sustained Release Formulations (1988), Pergamon, New York 57
87. Skelly J.P., Yau M.K., Elkins J.S., Yamamoto L.A., Shah V.P., and Barr W.H. Invitro topographical characterization as a predictor of invivo controlled release quinidine gluconate bioavailability. Drug Dev. Ind. Pharm. 12 (1986) 1177-1201
88. Tao J.C., Cussler E.L., and Evans D.F. Accelerating gallstone dissolution. Proc. Natl. Acad. Sci. U.S.A. 71 (1974) 3917-3921
89. Theeuwes F., and Bayne W. Dosage form index: an objective criterion for evaluation of controlled-release drug delivery systems. J. Pharm. Sci. 66 (1977) 1388-1392
90. Tyrer J.H., Eadie M.J., Sutherland J.M., and Hooper W.D. Outbreak of anticonvulsant intoxication in an Australian city. Br. Med. J. 4 (1970) 271-273
91. Varley A.B. The generic inequivalence of drugs. JAMA 206 (1968) 1745-1748
92. Wang T.T., Kwei T.K., and Frisch H.L. Diffusion in glassy polymers. 3. J. Polym. Sci. Part B: Polym. Phys. 7 (1969) 2019-2028
93. Wearley L., Pagone J., Streicher A., Wickman A., and Karim A. Possible in vitro model for explaining the effect on food on the absorption of theophylline from oral controlled release products. 12th International Symposium on Controlled Release of Bioactive Materials. Geneva, Switzerland (1985)
94. Weitschies W., Kosch O., Monnikes H., and Trahms L. Magnetic marker monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv. Drug Deliv. Rev. 57 (2005) 1210-1222
95. Wilderman M. Über die Geschwindigkeit molekularer und chemischer Reaktionen in heterogenen Systemen. Erster Teil. Z. Phys. Chem. 66 (1909) 445-495
96. Willmann S., Schmitt W., Keldenich J., and Dressman J.B. A physiologic model for simulating gastrointestinal flow and drug absorption in rats. Pharm. Res. 20 (2003) 1766-1771
97. Willmann S., Schmitt W., Keldenich J., Lippert J., and Dressman J.B. A physiological model for the estimation of the fraction dose absorbed in humans. J. Med. Chem. 47 (2004) 4022-4031
98. Wurster D.E., and Polli G.P. Investigation of drug release from solids. IV. Influence of adsorption on the dissolution rate. J. Pharm. Sci. 50 (1961) 403-406
99. Wurster D.E., and Taylor Jr. P.W. Dissolution kinetics of certain crystalline forms of prednisolone. J. Pharm. Sci. 54 (1965) 670-676
100. Yazdanian M., Briggs K., Jankovsky C., and Hawi A. The "high solubility" definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs. Pharm. Res. 21 (2004) 293-299
101. Yu L.X., Amidon G.L., Polli J.E., Zhao H., Mehta M.U., Conner D.P., Shah V.P., Lesko L.J., Chen M.L., Lee V.H., and Hussain A.S. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm. Res. 19 (2002) 921-925
102. Zdanovskii A.B. The role of the interphase solution in the kinetics of the solution of salts. Zhur. Fiz. Khim. (USSR) 20 (1946) 869-880